Hai Huang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Walled Carbon Nanotubes

Epidermal Growth Factor Receptor

Top Venues

Journal of translational medicine

Journal of experimental & clinical cancer research : CR

NPJ precision oncology

Biomaterials science

This page only lists publications with an associated author ORCID identifier.

Publications

Zhi Xiong, Tong Tong, Zhaoxiang Xie, Shunli Yu, Ruilin Zhuang, Qiang Jia, Shirong Peng, Bingheng Li, Junjia Xie, Kaiwen Li, Jun Wu, Hai Huang
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression. Biomaterials science 12 (3) (2024)
Bisheng Cheng, Lingfeng Li, Tianlong Luo, Qiong Wang, Yong Luo, Shoumin Bai, Kaiwen Li, Yiming Lai, Hai Huang
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Bisheng Cheng, Lingfeng Li, Tianlong Luo, Qiong Wang, Yong Luo, Shoumin Bai, Kaiwen Li, Yiming Lai, Hai Huang
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Qiong Wang, Bisheng Cheng, Sandeep Singh, Yiran Tao, Zhongqiu Xie, Fujun Qin, Xinrui Shi, Jingjing Xu, Chenxi Hu, Wanlong Tan, Hui Li, Hai Huang
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3. NPJ precision oncology 8 (1) (2024)
Bisheng Cheng, Lingfeng Li, Tianlong Luo, Qiong Wang, Yong Luo, Shoumin Bai, Kaiwen Li, Yiming Lai, Hai Huang
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Qiong Wang, Bisheng Cheng, Sandeep Singh, Yiran Tao, Zhongqiu Xie, Fujun Qin, Xinrui Shi, Jingjing Xu, Chenxi Hu, Wanlong Tan, Hui Li, Hai Huang
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3. NPJ precision oncology 8 (1) (2024)
Qiong Wang, Bisheng Cheng, Sandeep Singh, Yiran Tao, Zhongqiu Xie, Fujun Qin, Xinrui Shi, Jingjing Xu, Chenxi Hu, Wanlong Tan, Hui Li, Hai Huang
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3. NPJ precision oncology 8 (1) (2024)
Zhi Xiong, Tong Tong, Zhaoxiang Xie, Shunli Yu, Ruilin Zhuang, Qiang Jia, Shirong Peng, Bingheng Li, Junjia Xie, Kaiwen Li, Jun Wu, Hai Huang
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression. Biomaterials science (2024)
Zhi Xiong, Tong Tong, Zhaoxiang Xie, Shunli Yu, Ruilin Zhuang, Qiang Jia, Shirong Peng, Bingheng Li, Junjia Xie, Kaiwen Li, Jun Wu, Hai Huang
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression. Biomaterials science 12 (3) (2024)
Zean Li, Yiran Tao, Ze Gao, Shirong Peng, Yiming Lai, Kaiwen Li, Xu Chen, Hai Huang
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. Journal of translational medicine 21 (1) (2023)
Zean Li, Yiran Tao, Ze Gao, Shirong Peng, Yiming Lai, Kaiwen Li, Xu Chen, Hai Huang
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. Journal of translational medicine 21 (1) (2023)
Zean Li, Yiran Tao, Ze Gao, Shirong Peng, Yiming Lai, Kaiwen Li, Xu Chen, Hai Huang
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. Journal of translational medicine 21 (1) (2023)
Bisheng Cheng, Hai Huang
Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment. Cancer biology & medicine (2023)
Zean Li, Yiran Tao, Ze Gao, Shirong Peng, Yiming Lai, Kaiwen Li, Xu Chen, Hai Huang
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. Journal of translational medicine 21 (1) (2023)
Bisheng Cheng, Yiming Lai, Hao Huang, Shirong Peng, Chen Tang, Junxiu Chen, Tianlong Luo, Jilin Wu, Haixia He, Qiong Wang, Hai Huang
MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer. Environmental toxicology (2023)
Zean Li, Yiran Tao, Ze Gao, Shirong Peng, Yiming Lai, Kaiwen Li, Xu Chen, Hai Huang
SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. Journal of translational medicine 21 (1) (2023)
Qianghua Zhou, Xu Chen, Kai Yao, Yangjie Zhang, Haixia He, Hao Huang, Hao Chen, Shengmeng Peng, Ming Huang, Liang Cheng, Qiang Zhang, Ruihui Xie, Kaiwen Li, Tianxin Lin, Hai Huang
TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Jingtian Yang, Kaiwen Li, Yishan Zhang, Jintao Hu, Hao Liu, Wen Dong, Hai Huang, Tianxin Lin, Jian Huang, Wang He
Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictors. Cancer medicine (2023)
Ni Li, Qiuli Liu, Ying Han, Siyu Pei, Bisheng Cheng, Junyu Xu, Xiang Miao, Qiang Pan, Hanling Wang, Jiacheng Guo, Xuege Wang, Guoying Zhang, Yannan Lian, Wei Zhang, Yi Zang, Min-Jia Tan, Qintong Li, Xiaoming Wang, Yi-Chuan Xiao, Guo-Hong Hu, Jun Jiang, Hai Huang, Jun Qin
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression. Nature communications 13 (1) (2022)
Hao Huang, Weike Zeng, Fan Fan, Kuiqing Li, Kewei Xu, Hai Huang
Radiologically anatomic measurement analysis for the third sacral foramen and an efficient implantation protocol for sacral neuromodulation. Neurourology and urodynamics 41 (5) (2022)
Qianghua Zhou, Kaiwen Li, Yiming Lai, Kai Yao, Qiong Wang, Xiangyu Zhan, Shirong Peng, Wenli Cai, Wei Yao, Xingxing Zang, Kewei Xu, Jian Huang, Hai Huang
B7 score and T cell infiltration stratify immune status in prostate cancer. Journal for immunotherapy of cancer 9 (8) (2022)
Shirong Peng, Xinyu Zhang, Hao Huang, Bisheng Cheng, Zhi Xiong, Tao Du, Jun Wu, Hai Huang
Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer. APL bioengineering 6 (4) (2022)
Qiang-Hua Zhou, Kai-Wen Li, Xu Chen, Hai-Xia He, Sheng-Meng Peng, Shi-Rong Peng, Qiong Wang, Ze-An Li, Yi-Ran Tao, Wen-Li Cai, Ran-Yi Liu, Hai Huang
HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma. Journal for immunotherapy of cancer 8 (1) (2021)
Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li, Hai Huang
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer. Cancer biology & medicine (2021)